Trial of Beremagene Geperpavec (B-VEC) for Dystrophic Epidermolysis Bullosa. Guide SV, Gonzalez ME, Bagci IS, Agostini B, et al. N Engl J Med 2022;387:2211-2219.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Guide SV, Gonzalez ME, Bagci IS, Agostini B, et al. Trial of Beremagene Geperpavec (B-VEC) for Dystrophic Epidermolysis Bullosa. N Engl J Med 2022;387:2211-2219.
PMID: 36516090